R F van Vollenhoven Selected Research

R F van Vollenhoven Research Topics

Disease

24	Rheumatoid Arthritis 09/2019 - 01/2004
14	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2018 - 05/2000
10	Necrosis 11/2022 - 09/2004
7	Rheumatic Diseases (Rheumatism) 07/2019 - 04/2004
3	Ankylosing Spondylitis 11/2022 - 03/2017
3	Infections 08/2018 - 07/2011
2	Lupus Nephritis 01/2020 - 01/2004
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 06/2011
2	Psoriatic Arthritis 03/2017 - 02/2010
2	Drug Hypersensitivity Syndrome 11/2016 - 05/2015
2	Hypersensitivity (Allergy) 11/2015 - 02/2013
2	Pain (Aches) 02/2010 - 01/2010
1	Synovitis 01/2020
1	Gout 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2019
1	Neutropenia 08/2018
1	Fever (Fevers) 08/2018
1	Spondylarthropathies 03/2017
1	Fatigue 02/2016
1	Injection Site Reaction 11/2015
1	Disease Progression 05/2014
1	Neoplasms (Cancer) 02/2013
1	Melanoma (Melanoma, Malignant) 02/2013
1	Skin Neoplasms (Skin Cancer) 02/2013
1	Tuberculosis (Tuberculoses) 06/2010
1	Bacterial Infections (Bacterial Infection) 06/2010
1	Arthritis (Polyarthritis) 02/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2010
1	Lymphoma (Lymphomas) 09/2004
1	Nephritis 01/2004
1	Dermatitis 05/2000

Drug/Important Bio-Agent (IBA)

8	Biological ProductsIBA 07/2019 - 04/2004
8	Rituximab (Mabthera)FDA Link 01/2019 - 01/2004
6	Infliximab (Remicade)FDA Link 09/2019 - 04/2004
6	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 06/2009
5	Tumor Necrosis Factor InhibitorsIBA 07/2019 - 07/2008
5	Antirheumatic Agents (DMARD)IBA 06/2010 - 01/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009 - 09/2004
4	Adalimumab (Humira)FDA Link 07/2019 - 09/2004
3	Pharmaceutical PreparationsIBA 11/2022 - 07/2019
3	Etanercept (Enbrel)FDA Link 07/2019 - 09/2004
3	AutoantibodiesIBA 09/2017 - 03/2011
3	Monoclonal AntibodiesIBA 02/2016 - 01/2004
3	Certolizumab Pegol FDA Link 01/2011 - 06/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2016
2	CytokinesIBA 01/2020 - 06/2009
2	AntibodiesIBA 09/2019 - 02/2016
2	GSK2586184IBA 11/2016 - 05/2015
2	Complement System Proteins (Complement)IBA 02/2016 - 09/2005
2	TACI receptor-IgG Fc fragment fusion proteinIBA 11/2015 - 07/2011
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2015 - 08/2009
2	ametantrone (HAQ)IBA 02/2010 - 01/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2008 - 01/2004
2	Dehydroepiandrosterone (DHEA)IBA 08/2000 - 05/2000
1	InterleukinsIBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Rheumatoid FactorIBA 09/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Alkaline PhosphataseIBA 12/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	EnzymesIBA 11/2016
1	SRI-5 (SRI 5)IBA 02/2016
1	B-Cell Activating FactorIBA 02/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	tabalumabIBA 02/2016
1	Estrogens (Estrogen)FDA Link 02/2016
1	tocilizumab (atlizumab)FDA Link 05/2014
1	belimumabIBA 02/2013
1	C-Reactive ProteinIBA 02/2010
1	GlucocorticoidsIBA 02/2010
1	Prostaglandins AIBA 02/2010
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2009
1	Anti-Idiotypic AntibodiesIBA 12/2005
1	Proteins (Proteins, Gene)FDA Link 12/2005
1	Peptides (Polypeptides)IBA 12/2005
1	Anticardiolipin AntibodiesIBA 09/2004
1	Prednisolone (Predate)FDA LinkGeneric 01/2004
1	HDL CholesterolIBA 05/2000

Therapy/Procedure

4	Therapeutics 01/2015 - 10/2008
1	Precision Medicine 01/2018
1	Drug Therapy (Chemotherapy) 01/2015
1	Drug Tapering 05/2014
1	Biological Therapy 06/2011